Actuate Therapeutics is based in Grayslake, Illinois. It has raised $28M in total funding. Latest round: IPO.
Actuate Therapeutics funding overview
Actuate Therapeutics is based in Grayslake, Illinois. Actuate Therapeutics has raised $28M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in January 2024. The round record for Actuate Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Kairos Ventures, Bios Partners, DEFTA Partners, Tech Coast Angels. 4 distinct backers are named across the disclosed rounds.
Frequently asked about Actuate Therapeutics funding
How much has Actuate Therapeutics raised?
Actuate Therapeutics has raised $28M in total disclosed funding across the rounds on record.
Who has invested in Actuate Therapeutics?
Kairos Ventures, Bios Partners, DEFTA Partners, Tech Coast Angels are named among the investors backing Actuate Therapeutics.
What was the latest Actuate Therapeutics funding round?
The most recent disclosed round is an IPO, announced in January 2024.
Where is Actuate Therapeutics based?
Actuate Therapeutics is based in Grayslake, Illinois.
When did Actuate Therapeutics last raise?
The last disclosed Actuate Therapeutics round closed in January 2024 at IPO.
Round data for Actuate Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Grayslake and backer lists below.
